140 related articles for article (PubMed ID: 35878937)
1. Preferential Expansion of Foxp3
Stohl W; Yu N; Wu Y
Immunohorizons; 2022 Jul; 6(7):507-514. PubMed ID: 35878937
[TBL] [Abstract][Full Text] [Related]
2. A Phenotypic Screening Approach Using Human Treg Cells Identified Regulators of Forkhead Box p3 Expression.
Ding M; Brengdahl J; Lindqvist M; Gehrmann U; Ericson E; von Berg S; Ripa L; Malhotra R
ACS Chem Biol; 2019 Mar; 14(3):543-553. PubMed ID: 30807094
[TBL] [Abstract][Full Text] [Related]
3. Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4
Chen FY; Geng CA; Chou CK; Zheng JB; Yang Y; Wang YF; Li TZ; Li P; Chen JJ; Chen X
Phytomedicine; 2022 Dec; 107():154482. PubMed ID: 36202057
[TBL] [Abstract][Full Text] [Related]
4. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma.
Erfani N; Khademi B; Haghshenas MR; Mojtahedi Z; Khademi B; Ghaderi A
Immunol Invest; 2013; 42(2):81-90. PubMed ID: 23252863
[TBL] [Abstract][Full Text] [Related]
5. Low expressions of PD-L1 and CTLA-4 by induced CD4
Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions.
Pietruczuk M; Eusebio M; Kraszula L; Kupczyk M; Kuna P
J Biol Regul Homeost Agents; 2012; 26(4):627-39. PubMed ID: 23241113
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Regulatory T Cell-Related Markers (FOXP3, CTLA-4 and GITR) by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer.
Khalife E; Khodadadi A; Talaeizadeh A; Rahimian L; Nemati M; Jafarzadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3019-3025. PubMed ID: 30484986
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.
Montcuquet N; Mercier-Letondal P; Perruche S; Duperrier A; Couturier M; Bouchekioua A; Bonyhadi M; Ferrand C; Tiberghien P; Robinet E
Immunology; 2008 Nov; 125(3):320-30. PubMed ID: 18445006
[TBL] [Abstract][Full Text] [Related]
9. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
10. Multi-faceted inhibition of dendritic cell function by CD4
Seitz C; Liu S; Klocke K; Joly AL; Czarnewski PV; Tibbitt CA; Parigi SM; Westerberg LS; Coquet JM; Villablanca EJ; Wing K; Andersson J
J Autoimmun; 2019 Mar; 98():86-94. PubMed ID: 30616979
[TBL] [Abstract][Full Text] [Related]
11. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
12. In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4(+)CD25(+) T cells of patients with human T-lymphotropic virus type 1-associated myelopathy.
Ramirez E; Cartier L; Rodriguez L; Alberti C; Valenzuela MA
Braz J Med Biol Res; 2010 Nov; 43(11):1109-15. PubMed ID: 20945034
[TBL] [Abstract][Full Text] [Related]
13. CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis.
Tang AL; Teijaro JR; Njau MN; Chandran SS; Azimzadeh A; Nadler SG; Rothstein DM; Farber DL
J Immunol; 2008 Aug; 181(3):1806-13. PubMed ID: 18641318
[TBL] [Abstract][Full Text] [Related]
14. Pak2 is essential for the function of Foxp3+ regulatory T cells through maintaining a suppressive Treg phenotype.
O'Hagan KL; Miller SD; Phee H
Sci Rep; 2017 Dec; 7(1):17097. PubMed ID: 29213081
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4.
Wing JB; Ise W; Kurosaki T; Sakaguchi S
Immunity; 2014 Dec; 41(6):1013-25. PubMed ID: 25526312
[TBL] [Abstract][Full Text] [Related]
16. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
Ha D; Tanaka A; Kibayashi T; Tanemura A; Sugiyama D; Wing JB; Lim EL; Teng KWW; Adeegbe D; Newell EW; Katayama I; Nishikawa H; Sakaguchi S
Proc Natl Acad Sci U S A; 2019 Jan; 116(2):609-618. PubMed ID: 30587582
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
[TBL] [Abstract][Full Text] [Related]
18. Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
Paterson AM; Lovitch SB; Sage PT; Juneja VR; Lee Y; Trombley JD; Arancibia-Cárcamo CV; Sobel RA; Rudensky AY; Kuchroo VK; Freeman GJ; Sharpe AH
J Exp Med; 2015 Sep; 212(10):1603-21. PubMed ID: 26371185
[TBL] [Abstract][Full Text] [Related]
19.
Vaddi PK; Osborne DG; Nicklawsky A; Williams NK; Menon DR; Smith D; Mayer J; Reid A; Domenico J; Nguyen GH; Robinson WA; Ziman M; Gao D; Zhai Z; Fujita M
Front Immunol; 2023; 14():1173035. PubMed ID: 37197667
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria.
Barnes MJ; Griseri T; Johnson AM; Young W; Powrie F; Izcue A
Mucosal Immunol; 2013 Mar; 6(2):324-34. PubMed ID: 22910217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]